Demonstrated in vivo effect

Industry

CPC
C12N2760/18671

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2760/00ssRNA Viruses negative-sense

Current Industry

C12N2760/18671Demonstrated in vivo effect

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Temperature-based transient delivery of nucleic acids and proteins...
- Patent number 12,060,568
- Issue date Aug 13, 2024
- Elixirgen Therapeutics, Inc.
- Minoru S. H. Ko
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant human parainfluenza virus type 1 expressing a chimeric...
- Patent number 12,018,051
- Issue date Jun 25, 2024
- The USA, as represented by the Secretary, Department of Health and Human Serv...
- Peter Collins
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a...
- Patent number 11,591,372
- Issue date Feb 28, 2023
- The United States of America, as represented by the Secretary, Department of...
- Peter Collins
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Temperature-based transient delivery of nucleic acids and proteins...
- Patent number 11,421,248
- Issue date Aug 23, 2022
- Elixirgen Therapeutics, Inc.
- Minoru S. H. Ko
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anticancer agent comprising HVJ-E and immune checkpoint protein inh...
- Patent number 11,166,995
- Issue date Nov 9, 2021
- Osaka University
- Yasufumi Kaneda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing...
- Patent number 10,654,898
- Issue date May 19, 2020
- The United States of America, as represented by the Secretary, Department of...
- Peter Collins
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods comprising hydrocarbon-stapled polypeptides
- Patent number 10,259,848
- Issue date Apr 16, 2019
- Dana-Farber Cancer Institute, Inc.
- Loren D. Walensky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Attenuated parainfluenza virus (PIV) vaccines
- Patent number 7,951,383
- Issue date May 31, 2011
- The United States of America as represented by the Department of Health and H...
- Brian R. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polypeptide promoting vascular endothelial cell growth
- Patent number 7,807,176
- Issue date Oct 5, 2010
- Genomidea, Inc.
- Tomoyuki Nishikawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING...
- Publication number 20240309053
- Publication date Sep 19, 2024
- The United States of America, as represented by the Secretary, Department of...
- Peter Collins
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING...
- Publication number 20240197861
- Publication date Jun 20, 2024
- The USA, as represented by the Secretary, Department of Health and Human Serv...
- Ursula J. Buchholz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TEMPERATURE-BASED TRANSIENT DELIVERY OF NUCLEIC ACIDS AND PROTEINS...
- Publication number 20210381005
- Publication date Dec 9, 2021
- Elixirgen Therapeutics, Inc.
- Minoru S.H. KO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTICANCER AGENT COMPRISING HVJ-E AND IMMUNE CHECKPOINT PROTEIN INH...
- Publication number 20190275091
- Publication date Sep 12, 2019
- Osaka University
- Yasufumi KANEDA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
- Publication number 20160237123
- Publication date Aug 18, 2016
- Dana-Farber Cancer Institute, Inc.
- Loren D. Walensky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
- Publication number 20110318352
- Publication date Dec 29, 2011
- Dana-Farber Cancer Institute, Inc.
- Loren D. Walensky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Attenuated parainfluenza virus (PIV) vaccines
- Publication number 20080096264
- Publication date Apr 24, 2008
- The Government of the US, Represented by the Secretary, Dept. of Health & Hum...
- Brian R. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Gene Promoting Vascular Endothelial Cell Growth
- Publication number 20070281888
- Publication date Dec 6, 2007
- Tomoyuki Nishikawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Demonstrated in vivo effect

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Temperature-based transient delivery of nucleic acids and proteins...

Recombinant human parainfluenza virus type 1 expressing a chimeric...

Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a...

Temperature-based transient delivery of nucleic acids and proteins...

Anticancer agent comprising HVJ-E and immune checkpoint protein inh...

Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing...

Compositions and methods comprising hydrocarbon-stapled polypeptides

Attenuated parainfluenza virus (PIV) vaccines

Polypeptide promoting vascular endothelial cell growth

Patents Applicationslast 30 patents

RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING...

RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING...

TEMPERATURE-BASED TRANSIENT DELIVERY OF NUCLEIC ACIDS AND PROTEINS...

ANTICANCER AGENT COMPRISING HVJ-E AND IMMUNE CHECKPOINT PROTEIN INH...

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS

Attenuated parainfluenza virus (PIV) vaccines

Gene Promoting Vascular Endothelial Cell Growth